Research Reports
Pharmacovigilance Market Report 2021-26: Size, Trends, Forecast and Analysis of Key players
Published by IMARC Services Private Limited
Posted on September 6, 2021
Editorial & Advertiser disclosure
Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
According to the latest report by IMARC Group, The global pharmacovigilance market grew at a CAGR of around 10% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-26.
Pharmacovigilance (PV) refers to the pharmacological science dealing with the assessment, detection and prevention of unfavorable effects associated with pharmaceutical products. It plays a crucial role in identifying previously unknown adverse effects, recognizing changes in the severity or frequency, and assessing the risks and benefits of drugs to ascertain required actions. PV also certifies the accuracy of communicated information to patients and healthcare professionals. As a result, it is widely used to understand the effects of drugs on individuals worldwide.
Market Trends:
The growing incidences of lifestyle diseases, such as diabetes, hypertension, cardiac disorders, etc., have resulted in the growing consumption of drugs. This, along with the rising cases of adverse drug reactions (ADRs), is primarily driving the market growth. Additionally, the sudden outbreak of COVID-19 has resulted in the urgent need for a vaccine, which has created numerous opportunities for the market players. Moreover, several key manufacturers are introducing advanced platforms to ensure automated ADR reporting, thereby further contributing to the market growth. Besides this, various pharmaceutical manufacturers are increasingly outsourcing pharmacovigilance operations to third parties in order to increase internal resource flexibility and enhance productivity over shorter periods.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/pharmacovigilance-market/requestsample
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
read our latest report blog @ http://imarcgroup.weebly.com/
Global Pharmacovigilance Market Coverage and Segmentation 2021-2026:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Accenture plc
ArisGlobal LLC
BioClinica Inc. (Cinven Partners LLP)
Capgemini
Cognizant
International Business Machines Corporation
ICON plc.
IQVIA Inc.
ITClinical
Parexel International Corporation
Wipro Limited.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/pharmacovigilance-market
The report has segmented the market on the basis of Product Type, End-User and Region.
Breakup by Service Provider:
In-house
Contract Outsourcing
Breakup by Product Life Cycle:
Pre-clinical
Phase I
Phase II
Phase III
Phase IV
Breakup by Type:
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining
Breakup by Process Flow:
Case Data Management
Case Logging
Case Data Analysis
Medical Reviewing and Reporting
Signal Detection
Adverse Event Logging
Adverse Event Analysis
Adverse Event Review and Reporting
Risk Management System
Risk Evaluation System
Risk Mitigation System
Breakup by Therapeutic Area:
Oncology
Neurology
Cardiology
Respiratory Systems
Others
Breakup by End Use:
Pharmaceuticals Companies
Biotechnology Companies
Medical Device Companies
Others
Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Related Reports
Human insulin market: https://www.imarcgroup.com/human-insulin-market
Hemodialysis market: https://www.imarcgroup.com/hemodialysis-market
Hyperlipidemia drugs market: https://www.imarcgroup.com/hyperlipidemia-drugs-market
Blood culture test market: https://www.imarcgroup.com/blood-culture-test-market
GCC e-Health Market: https://www.imarcgroup.com/gcc-e-health-market
Brain Health Supplements Market: https://www.imarcgroup.com/brain-health-supplements-market
Brain Implants Market: https://www.imarcgroup.com/brain-implants-market
Biotech Ingredients Market: https://www.imarcgroup.com/biotech-ingredients-market
Blood Purification Equipment Market: https://www.imarcgroup.com/blood-purification-equipment-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
read our latest report blog @ https://imarcgroup.wordpress.com/
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
According to the latest report by IMARC Group, The global pharmacovigilance market grew at a CAGR of around 10% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-26.
Pharmacovigilance (PV) refers to the pharmacological science dealing with the assessment, detection and prevention of unfavorable effects associated with pharmaceutical products. It plays a crucial role in identifying previously unknown adverse effects, recognizing changes in the severity or frequency, and assessing the risks and benefits of drugs to ascertain required actions. PV also certifies the accuracy of communicated information to patients and healthcare professionals. As a result, it is widely used to understand the effects of drugs on individuals worldwide.
Market Trends:
The growing incidences of lifestyle diseases, such as diabetes, hypertension, cardiac disorders, etc., have resulted in the growing consumption of drugs. This, along with the rising cases of adverse drug reactions (ADRs), is primarily driving the market growth. Additionally, the sudden outbreak of COVID-19 has resulted in the urgent need for a vaccine, which has created numerous opportunities for the market players. Moreover, several key manufacturers are introducing advanced platforms to ensure automated ADR reporting, thereby further contributing to the market growth. Besides this, various pharmaceutical manufacturers are increasingly outsourcing pharmacovigilance operations to third parties in order to increase internal resource flexibility and enhance productivity over shorter periods.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/pharmacovigilance-market/requestsample
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
read our latest report blog @ http://imarcgroup.weebly.com/
Global Pharmacovigilance Market Coverage and Segmentation 2021-2026:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Accenture plc
ArisGlobal LLC
BioClinica Inc. (Cinven Partners LLP)
Capgemini
Cognizant
International Business Machines Corporation
ICON plc.
IQVIA Inc.
ITClinical
Parexel International Corporation
Wipro Limited.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/pharmacovigilance-market
The report has segmented the market on the basis of Product Type, End-User and Region.
Breakup by Service Provider:
In-house
Contract Outsourcing
Breakup by Product Life Cycle:
Pre-clinical
Phase I
Phase II
Phase III
Phase IV
Breakup by Type:
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining
Breakup by Process Flow:
Case Data Management
Case Logging
Case Data Analysis
Medical Reviewing and Reporting
Signal Detection
Adverse Event Logging
Adverse Event Analysis
Adverse Event Review and Reporting
Risk Management System
Risk Evaluation System
Risk Mitigation System
Breakup by Therapeutic Area:
Oncology
Neurology
Cardiology
Respiratory Systems
Others
Breakup by End Use:
Pharmaceuticals Companies
Biotechnology Companies
Medical Device Companies
Others
Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Related Reports
Human insulin market: https://www.imarcgroup.com/human-insulin-market
Hemodialysis market: https://www.imarcgroup.com/hemodialysis-market
Hyperlipidemia drugs market: https://www.imarcgroup.com/hyperlipidemia-drugs-market
Blood culture test market: https://www.imarcgroup.com/blood-culture-test-market
GCC e-Health Market: https://www.imarcgroup.com/gcc-e-health-market
Brain Health Supplements Market: https://www.imarcgroup.com/brain-health-supplements-market
Brain Implants Market: https://www.imarcgroup.com/brain-implants-market
Biotech Ingredients Market: https://www.imarcgroup.com/biotech-ingredients-market
Blood Purification Equipment Market: https://www.imarcgroup.com/blood-purification-equipment-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
read our latest report blog @ https://imarcgroup.wordpress.com/
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800